Terms: = Colorectal cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393 AND Treatment
3 results:
1. Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer.
Wyvekens N; Tsai HK; Sholl LM; Tucci J; Giannico GA; Gordetsky JB; Hirsch MS; Barletta JA; Acosta AM
Histopathology; 2022 Jun; 80(7):1050-1060. PubMed ID: 35395112
[TBL] [Abstract] [Full Text] [Related]
2. Magnesium treatment on methylation changes of transmembrane serine protease 2 (tmprss2).
Fan L; Zhu X; Zheng Y; Zhang W; Seidner DL; Ness R; Murff HJ; Yu C; Huang X; Shrubsole MJ; Hou L; Dai Q
Nutrition; 2021 Sep; 89():111340. PubMed ID: 34116393
[TBL] [Abstract] [Full Text] [Related]
3. Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.
Tran G; Hack SP; Kerr A; Stokes L; Gibbs P; Price T; Todd C
Asia Pac J Clin Oncol; 2013 Sep; 9(3):239-48. PubMed ID: 23279720
[TBL] [Abstract] [Full Text] [Related]
